🎧 ▶️ Press play below to listen.
Introduction
Lithium is best known as a cornerstone therapy for bipolar disorder, where it has been prescribed for decades as a mood stabilizer. However, emerging research suggests that this simple mineral salt may also hold significant promise for protecting the heart and blood vessels.
Far beyond its psychiatric applications, lithium appears to exert direct and indirect cardioprotective effects, ranging from improved heart structure and function to reduced risk of atherosclerosis, metabolic syndrome, and inflammation.
This article will explore the multifaceted ways in which lithium may shield against cardiovascular disease (CVD) and atherosclerosis, two of the world’s leading causes of death. We will examine evidence from human studies and animal models, unpack the mechanisms at play, and consider the broader implications for public health.
Why Cardiovascular Disease Matters
Cardiovascular disease remains the number one cause of death globally. According to the World Health Organization, an estimated 17.9 million people die each year from CVDs, accounting for 32% of all global deaths. Key contributors include atherosclerosis, hypertension, diabetes, smoking, and obesity.
Bipolar disorder itself is linked with an increased risk of cardiovascular disease. Factors include lifestyle behaviors, higher prevalence of smoking, obesity, and metabolic syndrome, as well as the side effects of some psychiatric medications.
Patients with bipolar disorder may die 10–20 years earlier than the general population, with cardiovascular disease being a leading cause of this excess mortality.
Given these sobering statistics, any treatment that both stabilizes mood and protects the heart could have transformative implications. Lithium may be one such agent.
Direct Cardioprotective and Cerebrovascular Effects of Lithium
Lower Risk of Cardiovascular and Cerebrovascular Disorders
Large population studies have shown that patients taking lithium exhibit a lower risk of cardiovascular and cerebrovascular events compared with patients with psychiatric disorders not treated with lithium.
This reduced risk persists even after adjusting for common cardiovascular risk factors and for the use of antipsychotic medications, which are known to worsen metabolic and cardiovascular profiles.
Specific Reductions in Vascular Events
Lithium’s protective benefits appear to be condition-specific. Clinical research indicates a lower incidence of angina pectoris, chronic ischemic heart disease, cerebral infarction, and myocardial infarction among lithium users.
These findings suggest that lithium not only improves general cardiovascular health but also lowers the likelihood of life-threatening events such as heart attacks and strokes.
Improved Cardiac Structure and Function
One of the more compelling observations is the association between lithium and healthier cardiac structure and function. In patients with bipolar disorder at high cardiovascular risk, lithium treatment correlates with:
- Lower left ventricular internal diameters (end-diastole and end-systole)
- Higher mitral valve E/A ratios, a measure of better diastolic function
- Improved global longitudinal strain performance, indicating stronger heart muscle contractions
Together, these metrics reflect a heart less prone to dysfunction and failure, even in individuals already vulnerable due to psychiatric illness.
Cardiac Remodeling and Hypertrophy
Following ischemia (restricted blood supply), the heart often undergoes remodeling, which can result in impaired function.
Lithium shows promise in modulating this remodeling process. It reduces pathological cardiac hypertrophy—an abnormal enlargement of the heart muscle that can lead to heart failure—by inhibiting the enzyme GSK-3β. At the same time, it supports physiological adaptive growth, preserving healthy heart function.
Inhibition of Cardiac Fibrosis
Fibrosis, or scarring of the heart muscle, worsens outcomes after heart attacks. Lithium, particularly at low doses, may inhibit cardiac fibrosis through multiple pathways:
- Activating PI3K/Akt/STAT3 signaling, which regulates macrophages and reduces inflammation
- Downregulating TGF-β and angiotensin II, both drivers of fibrosis
- Suppressing cardiac fibroblast migration and collagen synthesis
The result is less stiffening and scarring, which helps preserve cardiac output.
Enhanced Mitochondrial Function
The heart is an energy-hungry organ, and mitochondrial dysfunction contributes to many forms of heart disease. Lithium supports mitochondrial health by:
- Reducing oxidative stress
- Restoring mitochondrial membrane potential
- Preventing proton leakage
- Downregulating phosphorylated acetyl-CoA carboxylase 2 (p-ACC2) via GSK-3β inhibition
These actions help cardiomyocytes (heart muscle cells) maintain energy efficiency and resist damage.
Antiarrhythmic Potential
Arrhythmias, particularly ventricular arrhythmias, are dangerous complications after myocardial infarction. In animal models, lithium exhibits antiarrhythmic effects, protecting against potentially dangerous rhythm disturbances and enhancing post-infarction remodeling.
Lithium’s Anti-Atherosclerotic and Vascular Benefits
Decreased Lipid Accumulation and Plaque Formation
Animal studies demonstrate lithium’s ability to reduce lipid buildup in the aorta. It also decreases the expression of vascular cell adhesion molecule 1 (VCAM-1) and lowers macrophage infiltration into vessel walls—two critical steps in the development of atherosclerotic plaques.
Clearance of Macrophages in Plaques
A unique benefit of lithium is its role in selectively clearing macrophages in existing plaques. By reducing these inflammatory immune cells, lithium may stabilize plaques and reduce the risk of rupture, which is the event that typically triggers a heart attack or stroke.
Protection of the Endothelium
The endothelium—the delicate lining of blood vessels—plays a vital role in vascular health. Lithium protects endothelial cells by preventing calcium overload, preserving nitric oxide function, and reducing oxidative stress.
Inhibition of Vascular Smooth Muscle Cell (VSMC) Proliferation
Excessive proliferation and migration of VSMCs contribute to neointimal hyperplasia, a thickening of vessel walls that narrows arteries. Lithium inhibits this process, promoting healthier, more elastic blood vessels.
Clinical Measures of Vascular Health
In human studies, lithium use is linked with:
- Increased carotid compliance (greater arterial flexibility)
- Improved carotid elastic modulus
- Reduced carotid intima-media thickness (CIMT)
CIMT is a well-recognized marker of atherosclerosis and a strong predictor of future cardiovascular risk, including stroke. Clinical research shows that higher daily lithium doses are associated with less progression of CIMT, reflecting healthier arteries and a lower likelihood of cerebrovascular events such as cerebral infarction (ischemic stroke).
In fact, registry-based studies confirm that lithium users have a significantly reduced risk of stroke compared with individuals who have mood or psychotic disorders but are not treated with lithium.
Indirect Cardioprotective Mechanisms of Lithium
Anti-Inflammatory Effects
Inflammation is a core driver of atherosclerosis and heart disease. Lithium reduces inflammation by:
- Lowering levels of fractalkine (CX3CL1), a chemokine implicated in both psychiatric and cardiovascular pathology
- Modulating cytokines such as IL-1, IL-2, IL-4, IL-6, and TNF-α
- Influencing macrophage biology, promoting anti-inflammatory phenotypes
Through these mechanisms, lithium dampens chronic vascular inflammation, making arteries less prone to injury and plaque formation.
Improved Metabolic Health
Metabolic syndrome and diabetes are key risk factors for CVD. Lithium has shown benefits in animal models of diabetes by:
- Enhancing glucose tolerance
- Improving peripheral glucose utilization
- Ameliorating insulin resistance
By improving metabolic parameters, lithium indirectly lowers cardiovascular risk.
Mental Health Stabilization and Cardiac Outcomes
Patients with severe mood disorders often experience worse cardiovascular outcomes, partly due to poor adherence to healthy behaviors, substance use, and medication side effects. Lithium’s effectiveness in stabilizing mood indirectly improves cardiovascular health by enabling better self-care, treatment adherence, and lifestyle stability.
Additionally, lithium’s antisuicidal effects reduce overall mortality, including deaths from cardiovascular causes.
Broader Implications of Lithium’s Cardiovascular Benefits
The evidence suggests lithium may serve as a dual-purpose therapy: treating psychiatric disorders while simultaneously lowering cardiovascular risk. This is particularly valuable given the overlap between psychiatric illness and heart disease, where comorbidities amplify one another’s burden.
However, while the data are promising, it is critical to note:
- Some findings are derived from animal models, rather than human trials.
- Lithium requires careful dosing and monitoring due to its narrow therapeutic window. Toxicity risks include kidney dysfunction, thyroid disturbances, and neurological symptoms.
- More high-quality randomized controlled trials (RCTs) are needed to establish its cardioprotective profile in humans fully.
Still, the consistency of findings across multiple systems—structural, vascular, metabolic, and inflammatory—suggests a genuine protective role.
Potential Future Applications
Researchers are increasingly exploring low-dose lithium supplementation as a preventive measure for neurodegenerative diseases and cardiovascular health. Unlike traditional psychiatric doses, microdoses may provide cellular protection with fewer side effects.
If validated in clinical trials, low-dose lithium could join the ranks of aspirin and statins as a preventive agent against heart disease—though its unique mechanisms make it complementary rather than competitive.
How Much Lithium Are We Talking About?
When researchers study lithium’s heart benefits, they usually look at people taking lithium carbonate for bipolar disorder. These are prescription doses, large enough to reach blood levels that doctors measure with regular blood tests. A typical daily dose for mood stabilization contains about 170–225 mg of elemental lithium. That’s very different from the much smaller amounts found in supplements or in drinking water.
By comparison, a common supplement like 5 mg lithium orotate gives only a tiny fraction of that amount. It is not the dose studied that reaches the blood levels needed for the direct heart changes seen in patients on medical lithium.
At the other end of the spectrum, researchers have noticed that even trace amounts of lithium in drinking water—measured in micrograms, thousands of times smaller than a prescription dose—are linked with lower overall death rates in some communities. For example, studies in Japan and Texas found that people who lived in areas with slightly more lithium in their tap water had fewer deaths from all causes, including heart disease.
So, where does a 5 mg supplement fit? It lands in between: much higher than what you’d get from tap water, but still far below what doctors prescribe for bipolar disorder. This means we can’t assume it will work exactly like either one. It probably won’t reshape the heart the way medical doses do, but it may provide some of the gentler, protective effects seen in the drinking-water studies.
The big picture is that lithium appears to have a beneficial effect at multiple levels. High doses help stabilize mood and may directly protect the heart, while even tiny, natural exposures appear linked with longer life and lower risk of dying early.
A supplement dose of 5 mg orotate falls in the middle, and researchers are still learning exactly what that means for long-term heart health.
Lithium Orotate 5mg of Elemental Lithium for Cognition and Brain Health
Conclusion
Lithium, long recognized as a mainstay treatment for bipolar disorder, may also serve as a powerful protector of the heart and blood vessels. Its cardioprotective actions are multifaceted:
- Directly improving cardiac structure and function
- Reducing fibrosis, remodeling, and arrhythmias
- Supporting mitochondrial health
- Preventing atherosclerosis by stabilizing plaques, protecting the endothelium, and reducing vascular inflammation
- Indirectly lowering risk through improved metabolic health and mood stabilization.
While challenges remain—including the need for further clinical trials and careful dosing—the existing evidence positions lithium as an unexpected ally in cardiovascular health. If its benefits can be harnessed safely, lithium may emerge as a dual-action therapy, addressing both mental illness and the world’s most common killer: cardiovascular disease.
Don’t Get Sick!
💡 Support This Work
Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.
🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!
Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.
Related:
- Lithium Sparks New Hope In Battle Against Alzheimer’s Memory Loss
- Lithium: How This Simple Mineral Shapes the Brain and Protects Against Suicide
- The Amazing Lithium for COVID-19 and Long COVID
- Stunning Low Doses Of Lithium Really Improve Survival
- Your Calf Muscles Could Predict Your Lifespan
- Blue Spaces, Longer Lives: Unlock Nature’s Hidden Advantage
- Low Testosterone, Higher Mortality: What Two Major Studies Reveal About Hormone Health and How to Boost It Naturally
- Pfizer and Moderna shots increase all cause mortality: Denmark study
- Big Heart Benefits From Small Efforts: Discover VILPA
- Exercise Or Statins? Choose The Powerful Path To Longevity
- Unlock Longevity Now: 8 Healthy Habits That Defy Death
- How A Duchenne Smile Boosts Mood, Love, And Longevity
- The Sit and Rise Test Predicts How Long You’ll Live
References:
- Tsai S. The effects of lithium and inflammation on the atherosclerosis of older bipolar patients at high risk for cardiovascular disease. Eur Psychiatry. 2022 Sep 1;65(Suppl 1):S402. doi: 10.1192/j.eurpsy.2022.1018. PMCID: PMC9564629.
- Tsai SY, Shen RS, Kuo CJ, Chen PH, Chung KH, Hsiao CY, Huang SH. The association between carotid atherosclerosis and treatment with lithium and antipsychotics in patients with bipolar disorder. Aust N Z J Psychiatry. 2020 Nov;54(11):1125-1134. doi: 10.1177/0004867420952551. Epub 2020 Sep 8. PMID: 32900219.
- Ponzer K, Millischer V, Schalling M, Gissler M, Lavebratt C, Backlund L. Lithium and risk of cardiovascular disease, dementia and venous thromboembolism. Bipolar Disord. 2023 Aug;25(5):391-401. doi: 10.1111/bdi.13300. Epub 2023 Jan 25. PMID: 36651280.
- Chen P-H, Hsiao C-Y, Chiang S-J, et al. Cardioprotective potential of lithium and role of fractalkine in euthymic patients with bipolar disorder. Australian & New Zealand Journal of Psychiatry. 2023;57(1):104-114. doi:10.1177/00048674211062532
- Jiang J, He W, Huang H. Lithium in cardiovascular health and disease: Pharmacological and clinical implications. Eur J Pharmacol. 2025 Jul 15;999:177657. doi: 10.1016/j.ejphar.2025.177657. Epub 2025 May 3. PMID: 40324573.
- Fajardo, Val Andrew, et al. “Trace Lithium in Texas Tap Water Is Negatively Associated with All-Cause Mortality and Premature Death.” Applied Physiology, Nutrition, and Metabolism, vol. 43, no. 4, 2018, pp. 412–414. doi:10.1139/apnm-2017-0653. PubMed. PubMed
Image credits:
- Arterial wall-– Own work
© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases
Discover more from Don't Get Sick!
Subscribe to get the latest posts sent to your email.